You are here

  • Home
  • Archive
  • Volume 71, Issue 12
  • Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice

Citation Tools

Article menu
Basic and translational research
Extended report
Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Bykerk VP, Östör AJK, Alvaro-Gracia J, et al
Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice
Annals of the Rheumatic Diseases 2012;71:1950-1954.